Pressure BioSciences Inc. (PBIO) Just Might Have the Ideal Drug Delivery Technology for Cannabinoids
The tide of cannabis legalization continues to rise Medical cannabis market on pace to hit $56 billion in seven years Company’s proprietary technology improves the bioavailability of cannabinoids With the passage of laws permitting medicinal use of cannabis in at least 32 U.S. jurisdictions and Canada, producers of cannabinoids for medical purposes are racing to improve delivery methods for their formulations. Cannabinoids, such as cannabidiol (CBD), are hydrophobic (literally, afraid of water). In practice, this means they do not dissolve or emulsify readily in water, which may seem to pose a problem, since, by composition, the human body is more…







